中国神经再生研究(英文版) ›› 2023, Vol. 18 ›› Issue (12): 2727-2732.doi: 10.4103/1673-5374.373716

• 原著:脊髓损伤修复保护与再生 • 上一篇    下一篇

Fidgetin通过与微管末端结合蛋白3相互作用影响脊髓损伤轴突的再生

  

  • 出版日期:2023-12-15 发布日期:2023-06-15
  • 基金资助:
    国家自然科学基金项目(32070725,82001295,31970412);江苏省高等学校重点学科建设项目(PAPD)

Fidgetin interacting with microtubule end binding protein EB3 affects axonal regrowth in spinal cord injury

Chao Ma1, 2, Junpei Wang1, Qifeng Tu1, Weijuan Bo1, Zunlu Hu1, Run Zhuo1, Ronghua Wu1, Zhangji Dong1, Liang Qiang3, Yan Liu1, Mei Liu1, *#br#   

  1. 1Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, Jiangsu Province, China; 2Medical School of Nantong University, Nantong, Jiangsu Province, China; 3Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, PA, USA
  • Online:2023-12-15 Published:2023-06-15
  • Contact: Mei Liu, PhD, liumei@ntu.edu.cn.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, Nos. 32070725 (to ML), 82001295 (to RHW), 31970412 (to YL); and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.

摘要:

Fidgetin是一种微管切割蛋白,可通过修剪微管不稳定区来调节轴突生长、轴突再生和细胞迁移。由于微管不稳定区对于轴突起始、延伸和导航至关重要,因此通过调节Fidgetin以影响微管不稳定区可能具有促进脊髓损伤轴突再生的意义。实验构建了脊髓损伤和坐骨神经损伤大鼠模型,与脊髓损伤相比,周围神经损伤后不稳定微管中酪氨酸化微管蛋白持续升高,而Fidgetin水平则明显下降。且Fidgetin耗竭可增强脊髓损伤后轴突的再生,并伴随微管正末端紧密结合的微管末端结合蛋白3的显著增加。继而以RNA干扰方法敲低微管末端结合蛋白3或Fidgetin,发现微管末端结合蛋白3缺失没有改变Fidgetin表达,但Fidgetin缺失却可显著增加微管末端结合蛋白3的表达和分布,且可释放更多的微管末端结合蛋白3进入生长中的神经突起,从而增加酪氨酸化微管蛋白水平。然后在敲除微管末端结合蛋白3的同时过表达Fidgetin,发现Fidgetin可通过与微管末端结合蛋白3结合靶向正在生长中的微管末端,修剪酪氨酸修饰的微管;而缺少Fidgetin时,微管不稳定区延长,从而增加轴突的长度和分支数量。因此提示Fidgetin可作为促进脊髓损伤后轴突再生的新治疗靶点,且该研究揭示了Fidgetin优先切割不稳定微管的机制。

https://orcid.org/0000-0003-1168-6119 (Mei Liu)

关键词: Fidgetin, 轴突再生, 轴突分支, 微管动力学, 酪氨酸化微管, 乙酰化微管, 微管末端结合蛋白3, 轴突再生, 中枢神经损伤, 周围神经损伤

Abstract: Fidgetin, a microtubule-severing enzyme, regulates neurite outgrowth, axonal regeneration, and cell migration by trimming off the labile domain of microtubule polymers. Because maintenance of the microtubule labile domain is essential for axon initiation, elongation, and navigation, it is of interest to determine whether augmenting the microtubule labile domain via depletion of fidgetin serves as a therapeutic approach to promote axonal regrowth in spinal cord injury. In this study, we constructed rat models of spinal cord injury and sciatic nerve injury. Compared with spinal cord injury, we found that expression level of tyrosinated microtubules in the labile portion of microtubules continuously increased, whereas fidgetin decreased after peripheral nerve injury. Depletion of fidgetin enhanced axon regeneration after spinal cord injury, whereas expression level of end binding protein 3 (EB3) markedly increased. Next, we performed RNA interference to knockdown EB3 or fidgetin. We found that deletion of EB3 did not change fidgetin expression. Conversely, deletion of fidgetin markedly increased expression of tyrosinated microtubules and EB3. Deletion of fidgetin increased the amount of EB3 at the end of neurites and thereby increased the level of tyrosinated microtubules. Finally, we deleted EB3 and overexpressed fidgetin. We found that fidgetin trimmed tyrosinated tubulins by interacting with EB3. When fidgetin was deleted, the labile portion of microtubules was elongated, and as a result the length of axons and number of axon branches were increased. These findings suggest that fidgetin can be used as a novel therapeutic target to promote axonal regeneration after spinal cord injury. Furthermore, they reveal an innovative mechanism by which fidgetin preferentially severs labile microtubules. 

Key words: acetylated microtubules, axon regeneration, axonal branching, axonal regrowth, end binding protein 3, fidgetin, microtubule dynamics, sciatic nerve injury, spinal cord injury, tyrosinated microtubules